UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048869
Receipt number R000055693
Scientific Title Exploratory integrated analysis to build a pathologic finding, recurrence, survival predicting algorithm using artificial intelligence from clinical factors and image finding on thin-section computed tomography in patients with clinical stage IA non-small cell lung cancer
Date of disclosure of the study information 2022/09/07
Last modified on 2022/09/07 12:03:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory integrated analysis to build a pathologic finding, recurrence, survival predicting algorithm using artificial intelligence from clinical factors and image finding on thin-section computed tomography in patients with clinical stage IA non-small cell lung cancer

Acronym

AI PREDICTION

Scientific Title

Exploratory integrated analysis to build a pathologic finding, recurrence, survival predicting algorithm using artificial intelligence from clinical factors and image finding on thin-section computed tomography in patients with clinical stage IA non-small cell lung cancer

Scientific Title:Acronym

AI PREDICTION

Region

Japan


Condition

Condition

Non-small cell lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To develop the prediction model of cancer recurrence or pathological findings in lung cancer patients with stage I NSCLC.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic sensitivity and specificity of prediction of cancer recurrence by artificial intelligence prediction model.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male

Key inclusion criteria

Cohort 1
Satisfy one of the following.
1) Registered and eligible in JCOG0802/WJOG4607L
2) Registered and eligible in JCOG0804/WJOG4507L
3) Registered and eligible in JCOG1211.

Cohort 2
All of the following items are satisfied.
1) Non-small cell lung cancer (excluding low-grade malignant tumors) operated at the Department of Thoracic Surgery, National Cancer Center Hospital East from January 2003 to December 2014.
2) Performance status (PS) is 0 or 1 according to ECOG criteria.
3) Complete pathological resection.
4) 80 years old or younger at the time of surgery.
5) Clinical stage 0-IB.
6) Preoperative thin-section CT (with or without contrast enhancement, slice thickness: 10 mm or less) can be obtained by the research office.
7) Written informed consent has been obtained from the survivors to participate in this study.

Key exclusion criteria

Cohort 1
1) No thin-section image of the main tumor in CT images submitted for central image review
Cohort 2
1) A history of other cancers at the time of surgery.
2) Multiple lung cancers were observed at the time of surgery.
3) Preoperative treatment was performed.
4) The purpose of the surgery was biopsy or sublobar resection for compromised patients.
5) Insufficient data in the medical record required for this ancillary study.

Target sample size

3129


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Tsuboi

Organization

National cancer center hospital East

Division name

Department of thoracic surgery

Zip code

277-8577

Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan

TEL

0471331111

Email

kaokage@east.ncc.go.jp


Public contact

Name of contact person

1st name Keiju
Middle name
Last name Aokage

Organization

National cancer center hospital East

Division name

Department of thoracic surgery

Zip code

277-8577

Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan

TEL

0471331111

Homepage URL


Email

kaokage@east.ncc.go.jp


Sponsor or person

Institute

JCOG

Institute

Department

Personal name



Funding Source

Organization

AstraZeneca

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

M3 Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Hospital, East, Japan

Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan

Tel

0471331111

Email

irst@ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター東病院


Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 09 Month 06 Day

Date of IRB

2022 Year 09 Month 06 Day

Anticipated trial start date

2022 Year 09 Month 06 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2022 Year 09 Month 07 Day

Last modified on

2022 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055693